Related Funds
Fund Name | Location |
AbbVie | Chicago, Illinois, United States |
blue 9 capital | New York, New York, United States |
Celeres Investments | China, Hong Kong, Hong Kong Island |
Dane Creek Capital | Canada, Mississauga, Ontario |
GHS Ventures | - |
Hamilton Capital | Arizona, Tucson, United States |
Hatou Jituan | - |
Leton Capital | China, Qingdao, Shandong |
McDATA Corporation | Broomfield, Colorado, United States |
Mehta Ventures | California, La Habra, United States |
Norwest Mezzanine Partners | Minneapolis, Minnesota, United States |
NTT East | Japan, Tokyo |
Shanghai Taitun Investment Management | China, Shanghai |
Sharrp Ventures | India, Maharashtra, Mumbai |
SMW Capital | - |
Sova VC | England, London, United Kingdom |
Transmed | Beirut, Beyrouth, Lebanon |
Vesuvius Ventures | - |
Xinyu Renhe Innovation Investment | Beijing, Beijing, China |
Zhonghang Dexing | China, Fujian, Xiamen Shi |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Previa Medical | $2M | 16 Feb 2023 | Lyon, Rhone-Alpes, France | ||
01 Oct 2015 | France, Auvergne-Rhône-Alpes | ||||
Calixar | $1M | 24 Feb 2015 | Lyon, Rhone-Alpes, France | ||
FLEXOMA | $295K | 16 Sep 2014 | Villeurbanne, Auvergne-Rhône-Alpes | ||
Numvision | 09 Sep 2014 | France, Provence-Alpes-Côte d'Azur | |||
01 Jan 2014 | France, Auvergne-Rhône-Alpes | ||||
Short Edition | $590K | 22 Mar 2013 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Previa Medical | $2M | 16 Feb 2023 | Lyon, Rhone-Alpes, France | ||
01 Oct 2015 | France, Auvergne-Rhône-Alpes | ||||
Calixar | $1M | 24 Feb 2015 | Lyon, Rhone-Alpes, France | ||
FLEXOMA | $295K | 16 Sep 2014 | Villeurbanne, Auvergne-Rhône-Alpes | ||
Numvision | 09 Sep 2014 | France, Provence-Alpes-Côte d'Azur | |||
01 Jan 2014 | France, Auvergne-Rhône-Alpes | ||||
Short Edition | $590K | 22 Mar 2013 | Paris, Ile-de-France, France |